Еркафарм Препараты

Astellas Pharma EMEA celebrates its 10th annive...

Astellas licenses 4DMT’s AAV vector for ophthal...

Astellas gets FDA priority review for gastric c...

FDA Grants Full Approval for Astellas Pharma's ...

Asia Business Daily on Twitter: "Astellas Pharm...

About | Astellas Pharma Ltd

Astellas Pharma US on LinkedIn: FDA Grants Prio...

Astellas' Prostate Cancer Drug Available In Jap...

Astellas Pharma Inc. (4503N.MX) stock price, ne...

US FDA approves Astellas Pharma pill for menopa...

Astellas Offloads 5 Legacy Products to Germany’...

FDA Approves Astellas’ Non-hormonal Menopause T...

FDA blocks Astellas’ Claudin cancer drug over m...

Astellas Pharma on LinkedIn: 医薬品の枠を超えた...

Astellas Pharma

Pharmaceutical Technology

Главная | Astellas Pharma Russia

Атлас лекарственных растений - YouTube

Astellas, University of Tokyo extend partnershi...

Astellas Pharma to acquire Propella Therapeutic...

Japan's Astellas sees cancer drug fueling 29% p...

Astellas Sues Over New Myrbetriq Patent to Reca...

China Formally Arrests Japanese Employee of Dru...

Astellas Pharma Projects :: Photos, videos, log...

Astellas Pharma: A Contrarian Investment (OTCMK...

Astellas Pharma Joins Record Bond Sales by Japa...

Astellas

Astellas Trains Sights On Iveric Bio In $5.9 Bi...

Astellas Pharma - Global Web Site on Behance

Astellas introduces sustainable community initi...

Home | Astellas Pharma Canada, Inc.

Astellas Pharmaceuticals Establishes Open Innov...

Astellas Home page | Astellas Pharma Inc.

Astellas Home page | Astellas Pharma Inc.

Главная | Astellas Pharma Russia